The Cystic Fibrosis mutation "arms race": When less is more

Genetics in Medicine

Volumn 9, Issue 11, 2007, Pages 739-744

  Grody, Wayne W ^a   Cutting, Garry R ^b   Watson, Michael S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c American College of Medical Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS; ETHNIC DIFFERENCE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; NOTE; PATIENT EDUCATION;

ALLELES; CYSTIC FIBROSIS; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MUTATION; PHENOTYPE;

EID: 36248989104     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318159a331     Document Type: Note

References (33)

1. Grody WW. Cystic fibrosis: molecular diagnosis, population screening, and public policy. Arch Pathol Lab Med 1999;123:1041-1046.
2. NIH Consensus Statement Online. Genetic Testing for Cystic Fibrosis. Available at: http://text.nlm.nih.gov/nih/cdc/www/106txt.html. Accessed April 14-16, 1997.
3. NIH Consensus Statement. Genetic testing for cystic fibrosis. Arch Intern Med 1999;159:1529-1539.
4. Mennuti MT, Thomson E, Press N. Screening for cystic fibrosis carrier state. Obstet Gynecol 1999;93:456-461.
5. Grody WW, Desnick RJ. Cystic fibrosis population carrier screening: here at last - are we ready? Genet Med 2001;3:87-90.
6. Grody WW, Cutting G, Klinger K, Richards CS, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
7. Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation screening practices. Am J Hum Genet 1998;62:1252-1254.
8. Williams LO, Cole EC, Iglesias NI, Jordan RL, et al. Quality assurance in human molecular genetics testing: status and recommendations. Arch Pathol Lab Med 2003;127:1353-1358.
9. Grody WW. Quest for controls in molecular genetics. J Mol Diagn 2003;5:209-211.
10. Bernacki SH, Beck JC, Stankovic AK, Williams LO, et al. Genetically characterized positive control cell lines derived from residual clinical blood samples. Clin Chem 2005;51:2013-2024.
11. Palomaki GE, Bradley LA, Richards CS, Haddow JE. Analytic validity of cystic fibrosis testing: a preliminary estimate. Genet Med 2003;5:15-20.
12. Strom CM, Janeszco R, Quan F, Wang SB, et al. Technical validation of a TM Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel. J Mol Diagn 2006;8:371-375.
13. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 2001;3:168-176.
14. Wald NJ. Couple screening for cystic fibrosis. Lancet 1991;338:1318-1319.
15. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, et al. Cystic fibrosis population carrier screening: 2004 revision of the American College of Medical Genetics mutation panel. Genet Med 2004; 6:387-391.
16. Claustres M, Altieri JP, Guittard C, Templin C, et al. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med Genet 2004;5:19.
17. Monaghan KG, Highsmith WE, Amos J, Pratt VM, et al. Genotype-phenotype correlation and frequency of the 3199del6 cystic fibrosis mutation among I148T carriers: results from a collaborative study. Genet Med 2004;6:421-425.
18. Rohlfs EM, Zhou Z, Sugarman EA, Heim EI, et al. The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosis. Genet Med 2002;4:319-323.
19. Buller A, Olson S, Redman JB, Hantash F, et al. Frequency of the cystic fibrosis 3199del6 mutation in individuals heterozygous for I148T. Genet Med 2004;6:108-9.
20. Schrijver I, Ramalingam S, Sankaran R, Swanson S, et al. Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Mol Diagn 2005;7:289-299.
21. Alper OM, Wong LJ, Young S, Pearl M, et al. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat 2004;24:353.
22. Mercier B, Raguenes O, Estivill X, Morral N, et al. Complete detection of mutations in cystic fibrosis patients of Native American origin. Hum Genet 1994;94:629-632.
23. Macek M Jr, Mackova A, Hamosh A, Hilman BC, et al. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 1997;60:1122-1127.
24. Altman DG, Bland JM. Diagnostic tests 2: predictive values. BMJ 1994;309:102.
25. Tsongalis GJ, Belloni DR, Grody WW. Cystic fibrosis mutation analysis: how many is enough? Genet Med 2004;6:456-458.
26. Pratt VM, Brown T, Kam-Morgan L, Eisenberg M, et al. Referral testing for cystic fibrosis. Am J Hum Genet 2000;67(suppl 2):251.
27. McGinniss MJ, Chen C, Redman JB, Buller A, et al. Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples. Hum Genet 2005;118:331-338.
28. Whitten CF. Sickle-cell programming - an imperiled promise. N Engl J Med 1973;288:318-319.
29. Asch DA, Hershey JC, Dekay ML, Pauly MV, et al. Carrier screening for cystic fibrosis: costs and clinical outcomes. Med Decis Making 1998;18:202-212.
30. Browner CH, Preloran HM, Cox SJ. Ethnicity, bioethics, and prenatal diagnosis: the amniocentesis decisions of Mexican-origin women and their partners. Am J Public Health 1999;89:1658-1666.
31. Hughes C, Fasaye GA, LaSalle VH, Finch C. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51:107-114.
32. Vinzileos AM, Ananth CV, Smulian JC, Fisher AJ, et al. A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis. Obstet Gynecol 1998;91:529-534.
33. Doyle NM, Gardner MO. Prenatal cystic fibrosis screening in Mexican Americans: an economic analysis. Am J Obstet Gynecol 2003;189:769-774.